General Information
Version
8.6
Revision date
2024-07-02
Product name
Magnesium ethylate for synthesis
CAS No.
2414-98-4
REACH No
is
1.2.1 Relevant identified uses
Chemical for synthesis
Emergency telephone
+44 (0)870 8200418
Icons in SDS
Company Information
company name
Merck Life Science UK Limited
e-mail address of the competent person responsible for the Safety Data Sheet
TechnicalService@merckgroup.com
GHS Information
Signal word
Danger
Hazard Codes
Hazard statements (CLP)
H251, H319
Hazard statements
Code
Statements
H251
Self-heating; may catch fire
Section 2
SECTION 2: Hazards identification
2.2 Label elements
Labelling
Signal word
Danger Danger
Hazard statements
H251 Self-heating; may catch fire. H319 Causes serious eye irritation. H251 Self-heating; may catch fire.
Precautionary statements
P235 Keep cool. P264 Wash skin thoroughly after handling. P280 Wear protective gloves/ protective clothing/ eye protection/ face protection. P305 + P351 + P338 IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. P337 + P313 If eye irritation persists: Get medical advice/ attention. P403 + P235 Store in a well-ventilated place. Keep cool. P235 Keep cool. P280 Wear protective gloves/ protective clothing/ eye protection/ face protection. P403 + P235 Store in a well-ventilated place. Keep cool.
Supplemental label elements
EUH014 Reacts violently with water. Reduced Labeling (<= 125 ml) EUH014 Reacts violently with water.
2.3 Other hazards
This substance/mixture contains no components considered to be either persistent, bioaccumulative and toxic (PBT), or very persistent and very bioaccumulative (vPvB) at levels of 0.1% or higher.
ECOLOGICAL INFORMATION
The substance/mixture does not contain components considered to have endocrine disrupting properties according to REACH Article 57(f) or Commission Delegated regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 at levels of 0.1% or higher.
TOXICOLOGICAL INFORMATION
The substance/mixture does not contain components considered to have endocrine disrupting properties according to REACH Article 57(f) or Commission Delegated regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 at levels of 0.1% or higher.
